NDC 80425-0477-01 - Venlafaxine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0477
- Requested NDC
- 80425-0477-01
- Package NDCs from labels
- 80425-0477-1, 80425-0477-3, 80425-0477-2, 80425-0477-01
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2025-01-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Venlafaxine Hydrochloride - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2025-01-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0477-1 | Venlafaxine Hydrochloride | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 2 | |
| 80425-0477-2 | Venlafaxine Hydrochloride | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | 2 | |
| 80425-0477-3 | Venlafaxine Hydrochloride | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0477 | VENLAFAXINE HYDROCHLORIDE TABLET, EXTENDED RELEASE [ADVANCED RX OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250201_2cf6e6ad-7d00-0db1-e063-6394a90ab1ec.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0477-1 | EA - Each | 80425-0477 | 39e5e5ca-6655-403e-ba4d-7e1084c67689 | 1 | 2025-03-04 |
| 80425-0477-2 | EA - Each | 80425-0477 | 13cdee5a-42f8-452b-8a42-91036a74a949 | 1 | 2025-03-04 |
| 80425-0477-3 | EA - Each | 80425-0477 | 4a0eebb3-a622-477f-b111-a35026b9e660 | 1 | 2025-03-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Yves Saint Laurent All Hours Foundation Sunscreen Broad Spectrum SPF 30 Luminous Matte Foundation | OCTINOXATE AND TITANIUM DIOXIDE | L'Oreal USA Products Inc | 5711364c-f9b4-bfa6-e063-6294a90ace4a | 2026-07-20 | Warnings | 15FIX9V2JP |
| FUNGAL NAIL TREATMENT kit .cream. | PSEUDOLARIX AMABILIS BARK 1% | GETHSEMANE BRANCH CORPORATION | 56c9d9fa-09ad-e26a-e063-6394a90a0ed9 | 2026-07-17 | Warnings | 6DC9Q167V3 |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Global Equipment Company | bc93a1e8-aa3c-6735-e053-2995a90ad6e8 | 2026-07-16 | Warnings | 6DC9Q167V3 |
| Revitalize Energizing Eye Drops | NAPHAZOLINE HYDROCHLORIDE ,PROPYLENE GLYCOL | Revitalize Energy Inc. | 518aac87-1642-4b2f-bca1-b74d21261eea | 2026-07-16 | Warnings | 6DC9Q167V3 |
| Prid | ICHTHAMMOL, CALCIUM SULFIDE, CALENDULA OFFICINALIS FLOWERING TOP, ARNICA MONTANA, ECHINACEA ANGUSTIFOLIA, SILICON DIOXIDE, SULFUR | Hyland's Inc. | 49689eeb-7790-07f1-e063-6294a90a2df2 | 2026-07-16 | Warnings | ETJ7Z6XBU4 |
| Leg Cramps PM | OYSTER SHELL CALCIUM CARBONATE, CRUDE, CAUSTICUM, MATRICARIA RECUTITA, CINCHONA OFFICINALIS BARK, COPPER, LYCOPODIUM CLAVATUM SPORE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, TOXICODENDRON PUBESCENS LEAF, SILICON DIOXIDE, AND SULFUR | Hyland's Inc. | b0574a7e-88fa-417e-b6d5-60ced59eba47 | 2026-07-15 | Warnings | ETJ7Z6XBU4 |
| Jacksons Cell Salts SILICA 12X 12 | SILICEA | Zettl Health Inc. | 5647dafc-1fff-6a25-e063-6294a90a8b4f | 2026-07-10 | ETJ7Z6XBU4 | |
| Bombee Honey Daily Glow Shield Sunscreen | HOMOSALATE, OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE | ABT ASIA Inc. | 56112dff-b091-7a56-e063-6294a90a77d3 | 2026-07-08 | Warnings | 15FIX9V2JP |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | REMEDYREPACK INC. | 4e3053b9-cdec-4f4d-85ae-2e55cf1cc185 | 2026-07-08 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | REMEDYREPACK INC. | 50d3b487-9f65-4e2f-b6eb-9533964f8972 | 2026-07-08 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | REMEDYREPACK INC. | ac9b972d-8b8a-4727-90c2-b208f91272fd | 2026-07-08 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Stay Ageless Tinted Mineral Sunscreen | BROAD SPECTRUM SPF30 | DERMIO DERMATOLOGY LLC | 562f5b0d-6a10-305d-e063-6394a90a5980 | 2026-07-08 | Warnings | 15FIX9V2JP |
| Stay Ageless Tinted Mineral Sunscreen | BROAD SPECTRUM SPF30 | Suzanne's Skin2soul LLC | 562fbaa6-f93a-5ec4-e063-6294a90a9634 | 2026-07-08 | Warnings | 15FIX9V2JP |
| Aussie Betta Tallow Sunscreen SPF50 SPF50 | TITANIUM DIOXIDE AND ZINC OXIDE SUNSCREEN | AUSSIE BETTA HEALTHY CARE PTY LTD | 56007d82-ff5b-6c26-e063-6294a90a09b6 | 2026-07-07 | Warnings | 15FIX9V2JP |
| Artificial Tears | ARTIFICIAL TEARS | AvPAK | f18bebf2-1936-658f-e053-2a95a90a5012 | 2026-07-07 | Warnings | 3NXW29V3WO |
| EELHOE Body Coverage Perfector | TITANIUM DIOXIDE | Shantou Eelhoe Daily Chemical Technology Co., Ltd. | 5610c3b7-456b-3bc1-e063-6394a90a3fa8 | 2026-07-07 | Warnings | 15FIX9V2JP |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Yaopharma Co., Ltd. | 38fd2c97-cd30-2f7d-e054-00144ff8d46c | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| venlafaxine | VENLAFAXINE HYDROCHLORIDE | REMEDYREPACK INC. | 4a82cef5-693e-46e9-90c4-bff753cdce37 | 2026-07-06 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Premier Tinted Mineral Sunscreen | BROAD SPECTRUM SPF30 | Emerald Aesthetics LLC | 55f88dd1-346c-22a5-e063-6294a90a711f | 2026-07-06 | Warnings | 15FIX9V2JP |
| OHUI Ultimate Cover CC Cushion Compact 02 Natural Beige | TITANIUM DIOXIDE | LG H&H Co., Ltd. | d307471c-6cc6-ce48-e053-2995a90a3e02 | 2026-07-02 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.